Byoung-Taek Choi

Title: Byoung-Taek Choi: Innovator in Pharmaceutical Purification

Introduction

Byoung-Taek Choi is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical purification, holding 2 patents that showcase his innovative approaches.

Latest Patents

His latest patents include a method for purifying teicoplanin A, which involves a multi-step process. This process includes a primary pre-purification step using a synthetic adsorbent, followed by a secondary pre-purification step with a high cross-linkage cation exchange resin. The final purification step utilizes a reversed phase resin, resulting in teicoplanin A with higher purity through a relatively simple process that minimizes the use of organic solvents. Another patent involves a nystatin-resistant mutant microorganism, Aspergillus terreus CLS 247-13, which is designed for preparing triol heptanoic acid. This mutant demonstrates high productivity and can be widely used in industrial applications.

Career Highlights

Byoung-Taek Choi has worked with prominent companies such as Ckd Bio Corp. and Chong Kun Dang Pharmaceutical Corporation. His experience in these organizations has contributed to his expertise in the pharmaceutical industry.

Collaborations

He has collaborated with notable coworkers, including Tae-Won Kang and Gang-Sun Choi, further enhancing his innovative work in the field.

Conclusion

Byoung-Taek Choi's contributions to pharmaceutical purification through his patents reflect his dedication to innovation and improvement in the industry. His work continues to influence the development of effective pharmaceutical processes.